Hikal reappoints Sameer Hiremath as Chairman and MD; starts Panoli personal-care production
Hikal shareholders approved Sameer Hiremath’s five-year term as Chairman and Managing Director from October 2026. The life-sciences supplier has also commenced commercial production at a cGMP multipurpose facility in Panoli, Gujarat, expanding its personal-care manufacturing capability.
What happened
Hikal shareholders appointed Sameer Hiremath Chairman and MD for five years. The Indian life-sciences supplier has begun commercial personal-care production at
Key facts
- Five-year Chairman & Managing Director term from October 1, 2026 to September 30, 2031
- Rs. 0.40 final dividend per share
- 38th Annual General Meeting
- Five manufacturing facilities
- EcoVadis Gold rating; top 5% globally assessed companies
What changed
Hikal shareholders appointed Sameer Hiremath Chairman and MD for five years. The Indian life-sciences supplier has begun commercial personal-care production at a cGMP multipurpose facility in Panoli, Gujarat, expanding its beauty and personal-care manufacturing capabilities.
Why this matters
Hikal’s leadership continuity and new Panoli cGMP facility could give beauty operators a more stable domestic source for scalable personal-care manufacturing.
What to watch
- Disclosure of Panoli facility capacity, utilization, product categories and first commercial customer wins.
- New customer approvals from large FMCG, beauty, pharmacy-beauty or global contract-manufacturing buyers.
- Personal-care segment revenue growth, margin commentary and order-book visibility in Hikal earnings releases.
- Additional capex, debottlenecking or regulatory certifications at Panoli.
- Changes in Indian import dependence, tariffs, compliance rules or customer sourcing strategies for cosmetic ingredients.